Parkinson's Disease development is categorized using a few staging schemes. The Hoehn and Yahr Stages and the Unified Parkinson's Disease Rating Scale (UPDRS) are the two most well-known staging systems.
In 1967, Hoehn and Yahr defined five stages of Parkinson's Disease based on the degree of clinical dysfunction. Clinicians use it to chart the course of motor symptoms in Parkinson's disease.
Mild symptoms that often only affect one side of the body characterize this stage. There may be tremors or other movement problems, but they are often minor and have little influence on daily activities. There are modifications to walking, facial expressions, and posture.
Bilateral symptoms occur, affecting both sides of the body. Tremors, rigidity, and bradykinesia become more pronounced. Movements may become slower, and the person may have balance and coordination issues. Activities of daily living can still be performed independently, but with more effort
Significant impairment in balance and coordination. Slowness of movement (bradykinesia) becomes more apparent . Falls become more frequent and daily activities require assistance.
Tremors and rigidity may still be present, but they are generally less pronounced.
The symptoms are completely established and profoundly incapacitating. The individual can still walk and stand without assistance but may need to use a cane/walker for safety. The individual need extensive assistance with everyday tasks and is unable to live alone.
The most advanced stage, characterized by a high level of disability and dependence on others for daily activities. The individual may be confined to a wheelchair or bed. Symptoms may include severe tremors, rigidity, and bradykinesia.
The UPDRS is a comprehensive tool used to evaluate various aspects of Parkinson's Disease, including motor function, activities of daily living, mental function, and complications.
The Unified Parkinson's Disease Rating Scale (UPDRS) is a comprehensive tool used to evaluate various aspects of Parkinson's disease, including motor function, activities of daily living, mental function, and complications. The UPDRS is summarized below:
The UPDRS gives clinicians with significant information for monitoring and tracking the development of Parkinson's Disease. It aids in the direction of treatment decisions and the monitoring of response to therapies.
The scale also provides as a standard language for communicating with patients and comparing their conditions across different healthcare settings and research investigations.
It's crucial to remember that the UPDRS is a standardized assessment instrument, but it should be used in conjunction with a full clinical examination by a Parkinson's Disease expert.
Medical Disclaimer: The medical information provided is intended for informational and awareness purposes only. IT does not constitute medical advice. It is essential to consult your MOVEMENT DISORDER SPECIALIST for specific instructions and guidelines regarding your medical and health-related concerns.
Copyright © 2024 ACT4PARKINSONS - All Rights Reserved.
Powered by KCSLOGICGROUP
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.